A newly identified molecule called OLE helped restore the brain’s immune cells to a more protective state in Alzheimer’s ...
According to the study published by Sciencedaily, OLE helps microglia surround and contain beta-amyloid plaques, reducing ...
Researchers are decoding how signals move between body and brain, with implications for how we understand and treat ...
HOUSTON, JULY 1, 2026 ― A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...
For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable ...
Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...
Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.
Summary: Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized the treatment of liquid blood cancers by engineering a patient’s own immune cells to destroy malignant targets, replicating ...
Science Focus on MSN
What really causes autism? We're about to find out
New biotech is helping scientists pull back the curtain on the developing brain and reveal the causes of the condition ...
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today provides shareholders a ...
Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.
The first participant has been treated in a landmark clinical trial of cellular reprogramming, which aims to rejuvenate aging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results